Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
drugs
2
×
fda
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
american society of clinical oncology
applied therapeutics
biosimilars
biotech
blueprint medicines
breast cancer
cell therapy
christopher heery
What
fda
ahead
approved
asco
bio
branded
cancer
choices
commissioner
consumers
costly
counterweight
deeper
dna
drug
drugs
elevatebio
fingerprint
generic
genetic
going
graft
matter
medications
medicine
nd
new
oks
rises
roundup
second
supposed
targets
tenure
time
tissues
tumor's
world
Language
Current search:
roche
×
drugs
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
